Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Transplantation
Volume 2018, Article ID 4863187, 5 pages
https://doi.org/10.1155/2018/4863187
Case Report

Liver Transplant for Unusually Large Polycystic Liver Disease: Challenges and Pitfalls

1Department of Surgery, Division of Abdominal Transplant Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
2Division of Gastroenterology and Hepatology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA

Correspondence should be addressed to Chirag Sureshchandra Desai; ude.cnu.dem@iased_garihc

Received 6 December 2017; Accepted 4 January 2018; Published 1 February 2018

Academic Editor: Ryszard Grenda

Copyright © 2018 Pablo Serrano Rodriguez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Roskams and V. Desmet, “Embryology of extra- and intrahepatic bile ducts, the ductal plate,” Anatomical Record, vol. 291, no. 6, pp. 628–635, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. M. Reynolds, C. T. Falk, A. Li et al., “Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1,” American Journal of Human Genetics, vol. 67, no. 6, pp. 1598–1604, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. G. T. Everson and M. R. G. Taylor, “Management of polycystic liver disease,” Current Fungal Infection Reports, vol. 7, no. 1, pp. 19–25, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. C. Hogan, T. V. Masyuk, L. J. Page et al., “Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease,” Journal of the American Society of Nephrology, vol. 21, no. 6, pp. 1052–1061, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. G. I. Kirchner, K. Rifai, T. Cantz et al., “Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation,” Liver Transplantation, vol. 12, no. 8, pp. 1268–1277, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Uddin, J. K. Ramage, B. Portmann et al., “Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment,” Gut, vol. 36, no. 1, pp. 142–145, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. Q. Qian, H. Du, B. F. King et al., “Sirolimus reduces polycystic liver volume in ADPKD patients,” Journal of the American Society of Nephrology, vol. 19, no. 3, pp. 631–638, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Chrispijn, T. J. G. Gevers, J. C. Hol, R. Monshouwer, H. M. Dekker, and J. P. H. Drenth, “Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: Results from a randomized controlled trial,” Journal of Hepatology, vol. 59, no. 1, pp. 153–159, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. E. VanSonnenberg, J. T. Wroblicka, H. B. D'Agostino et al., “Symptomatic hepatic cysts: Percutaneous drainage and sclerosis,” Radiology, vol. 190, no. 2, pp. 387–392, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Iijima, T. Suwabe, K. Sumida et al., “Prediction of hepatic cyst recurrence after minocycline hydrochloride aspiration sclerotherapy using cyst computed tomography values,” Hepatology Research, vol. 47, no. 5, pp. 419–424, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Kabbej, A. Sauvanet, D. Chauveau, O. Farges, and J. Belghiti, “Laparoscopic fenestration in polycystic liver disease,” British Journal of Surgery, vol. 83, no. 12, pp. 1697–1701, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Koperna, S. Vogl, U. Satzinger, and F. Schulz, “Nonparasitic cysts of the liver: results and options of surgical treatment,” World Journal of Surgery, vol. 21, no. 8, pp. 850–855, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Vons, D. Chauveau, E. Martinod, C. Smadja, F. Capron, J. P. Grunfeld et al., “Liver resection in patients with polycystic liver disease,” Gastroenterologie clinique et biologique, vol. 22, pp. 50–54, 1998. View at Google Scholar
  14. F. Que, D. M. Nagorney, J. B. Gross Jr., and V. E. Torres, “Liver resection and cyst fenestration in the treatment of severe polycystic liver disease,” Gastroenterology, vol. 108, no. 2, pp. 487–494, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Van Keimpema, D. B. De Koning, B. Van Hoek et al., “Patients with isolated polycystic liver disease referred to liver centres: Clinical characterization of 137 cases,” Liver International, vol. 31, no. 1, pp. 92–98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Arrazola, D. Moonka, R. G. Gish, and G. T. Everson, “Model for End-Stage Liver Disease (MELD) exception for polycystic liver disease,” Liver Transplantation, vol. 12, no. 12, pp. S110–S111, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. U. S. Department of, U.S. Department of Health & Human Services. Guidance on MELD PELD exception review. Organ Procure Transplant Network, US Dep Heal Hum Serv 2015. https://optn.transplant.hrsa.gov/resources/by-organ/liver-intestine/guidance-on-meld-peld-exception-review/.
  18. C. M. Flavin, Guidance to Liver Transplant Programs and the National Liver Review Board for Adult MELD Exception Review OPTN/UNOS Liver and Intestinal Organ Transplantation Committee. OPTN/UNOS Liver Intest Organ Transplant Comm 2016. https://optn.transplant.hrsa.gov/governance/public-comment/adult-meld-exception-review-guidance/.
  19. E. S. Orman, M. E. Mayorga, S. B. Wheeler et al., “Declining liver graft quality threatens the future of liver transplantation in the United States,” Liver Transplantation, vol. 21, no. 8, pp. 1040–1050, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. J. P. H. Drenth, M. Chrispijn, D. M. Nagorney, P. S. Kamath, and V. E. Torres, “Medical and surgical treatment options for polycystic liver disease1,” Hepatology, vol. 52, no. 6, pp. 2223–2230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. G. T. Everson, M. R. G. Taylor, and R. B. Doctor, “Polycystic disease of the liver,” Hepatology, vol. 40, no. 4, pp. 774–782, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. S. D. Doshi, T. Bittermann, T. D. Schiano, and D. S. Goldberg, “Waitlisted Candidates with Polycystic Liver Disease Are More Likely to be Transplanted Than Those with Chronic Liver Failure,” Transplantation, vol. 101, no. 8, pp. 1838–1844, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Schnelldorfer, V. E. Torres, S. Zakaria, C. B. Rosen, and D. M. Nagorney, “Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation,” Annals Surgery, vol. 250, pp. 112–118, 2009. View at Google Scholar
  24. E. S. Orman, A. S. Barritt, S. B. Wheeler, and P. H. Hayashi, “Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death,” Liver Transplantation, vol. 19, no. 1, pp. 59–68, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Abu-Wasel, C. Walsh, V. Keough, and M. Molinari, “Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases,” World Journal of Gastroenterology, vol. 19, no. 35, pp. 5775–5786, 2013. View at Publisher · View at Google Scholar · View at Scopus